D. Häfner

2.2k total citations
73 papers, 1.7k citations indexed

About

D. Häfner is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Infectious Diseases. According to data from OpenAlex, D. Häfner has authored 73 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 21 papers in Cardiology and Cardiovascular Medicine and 15 papers in Infectious Diseases. Recurrent topics in D. Häfner's work include Cardiac electrophysiology and arrhythmias (16 papers), Ion channel regulation and function (13 papers) and Antimicrobial Resistance in Staphylococcus (12 papers). D. Häfner is often cited by papers focused on Cardiac electrophysiology and arrhythmias (16 papers), Ion channel regulation and function (13 papers) and Antimicrobial Resistance in Staphylococcus (12 papers). D. Häfner collaborates with scholars based in Germany, United States and Netherlands. D. Häfner's co-authors include U. Borchard, Michael Kresken, F. Berger, Michael Wilhelm, I. Lombeck, Franz‐Josef Schmitz, Thomas K. Hoffmann, H. Bier, Malte Kelm and Michael Preik and has published in prestigious journals such as PLoS ONE, The Science of The Total Environment and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

D. Häfner

70 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Häfner Germany 26 569 306 281 202 172 73 1.7k
Sanjay Batra United States 33 1.4k 2.4× 166 0.5× 252 0.9× 389 1.9× 86 0.5× 88 3.6k
B. Sweder van Asbeck Netherlands 33 632 1.1× 135 0.4× 92 0.3× 236 1.2× 103 0.6× 67 2.6k
Ying Dong China 30 820 1.4× 189 0.6× 100 0.4× 373 1.8× 105 0.6× 107 2.6k
Annette J. Theron South Africa 30 601 1.1× 240 0.8× 84 0.3× 444 2.2× 54 0.3× 128 2.7k
Pinhua Pan China 28 1.0k 1.8× 467 1.5× 64 0.2× 576 2.9× 90 0.5× 144 2.6k
Joannes J.M. Marx Netherlands 32 445 0.8× 146 0.5× 83 0.3× 179 0.9× 91 0.5× 96 3.2k
Charles E. McCall United States 35 1.2k 2.2× 115 0.4× 61 0.2× 485 2.4× 113 0.7× 74 3.3k
Frances W.J. Beck United States 28 548 1.0× 149 0.5× 122 0.4× 209 1.0× 31 0.2× 63 3.4k
Xiaoyang Jiao China 24 431 0.8× 177 0.6× 83 0.3× 219 1.1× 33 0.2× 82 1.6k
Charles R. Esther United States 30 804 1.4× 334 1.1× 449 1.6× 699 3.5× 22 0.1× 93 3.4k

Countries citing papers authored by D. Häfner

Since Specialization
Citations

This map shows the geographic impact of D. Häfner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Häfner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Häfner more than expected).

Fields of papers citing papers by D. Häfner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Häfner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Häfner. The network helps show where D. Häfner may publish in the future.

Co-authorship network of co-authors of D. Häfner

This figure shows the co-authorship network connecting the top 25 collaborators of D. Häfner. A scholar is included among the top collaborators of D. Häfner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Häfner. D. Häfner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kresken, Michael, Paul G. Higgins, Danuta Stefanik, et al.. (2022). The evolution of carbapenem resistance determinants and major epidemiological lineages among carbapenem‐resistant Acinetobacter baumannii isolates in Germany, 2010‐2019. International Journal of Antimicrobial Agents. 60(5-6). 106689–106689. 14 indexed citations
2.
Körber-Irrgang, Barbara, et al.. (2012). Comparative activity of pradofloxacin and marbofloxacin against coagulase‐positive staphylococci in a pharmacokinetic–pharmacodynamic model based on canine pharmacokinetics. Journal of Veterinary Pharmacology and Therapeutics. 35(6). 571–579. 6 indexed citations
3.
Hoffmann, Thomas K., Enikö Sonkoly, U. Häuser, et al.. (2008). Alterations in the p53 pathway and their association with radio- and chemosensitivity in head and neck squamous cell carcinoma. Oral Oncology. 44(12). 1100–1109. 50 indexed citations
4.
Sproll, Christoph, Thomas K. Hoffmann, Kathrin Scheckenbach, et al.. (2008). Is there a role for the Fas-/Fas-Ligand pathway in chemoresistance of human squamous cell carcinomas of the head and neck (SCCHN)?. Oral Oncology. 45(1). 69–84. 6 indexed citations
5.
Kresken, Michael, et al.. (2005). Surveillance of linezolid resistance in Germany, 2001–2002. Clinical Microbiology and Infection. 11(1). 39–46. 21 indexed citations
6.
Schmitz, Franz‐Josef, Andreas Beyer, Emmanuelle Charpentier, et al.. (2003). Toxin‐Gene Profile Heterogeneity among Endemic Invasive European Group A Streptococcal Isolates. The Journal of Infectious Diseases. 188(10). 1578–1586. 87 indexed citations
7.
Mahler, Hellmut, et al.. (2003). Kinetics of kavain and its metabolites after oral application. Journal of Chromatography B. 789(1). 115–130. 28 indexed citations
8.
Schwahn, Bernd, et al.. (2003). Pharmacokinetics of oral betaine in healthy subjects and patients with homocystinuria. British Journal of Clinical Pharmacology. 55(1). 6–13. 88 indexed citations
9.
Hoffmann, Thomas K., D. Häfner, Vera Balz, et al.. (2002). Antitumor activity of protein kinase C inhibitors and cisplatin in human head and neck squamous cell carcinoma lines. Anti-Cancer Drugs. 13(1). 93–100. 40 indexed citations
10.
11.
Häfner, D., et al.. (1999). Drug resistance among clinical isolates of frequently encountered bacterial species in central Europe during 1975–1995. Infection. 27(S2). S2–S8. 50 indexed citations
12.
Berger, F., et al.. (1998). Different inhibition patterns of tedisamil for fast and slowly inactivating transient outward current in rat ventricular myocytes. Naunyn-Schmiedeberg s Archives of Pharmacology. 357(3). 291–298. 11 indexed citations
13.
Borchard, U., F. Berger, D. Häfner, Derik Hermsen, & O. Picker. (1997). Elektrophysiologische Wirkungen von K+ und Mg2+ im Hypoxiemodell. Herz. 22(S1). 28–35.
14.
Thomé, Ulrich, F. Berger, U. Borchard, & D. Häfner. (1997). Modulation of pacemaker activity in sheep cardiac Purkinje fibers by stimulation of ?-adrenoceptor subtypes. Basic Research in Cardiology. 92(1). 25–34. 6 indexed citations
15.
Dunlap, Nancy E., et al.. (1995). Laboratory Contamination of Mycobacterium Tuberculosis Cultures. American Journal of Respiratory and Critical Care Medicine. 152(5). 1702–1704. 32 indexed citations
16.
Berger, F., et al.. (1995). Inhibition of pacemaker current by the bradycardic agent ZD 7288 is lost use-dependently in sheep cardiac Purkinje fibres. Naunyn-Schmiedeberg s Archives of Pharmacology. 353(1). 64–72. 6 indexed citations
17.
Berger, F., et al.. (1994). Effects of the bradycardic agent ZD 7288 on membrane voltage and pacemaker current in sheep cardiac Purkinje fibres. Naunyn-Schmiedeberg s Archives of Pharmacology. 350(6). 677–84. 9 indexed citations
18.
Wilhelm, Michael, F. K. Ohnesorge, I. Lombeck, & D. Häfner. (1989). Uptake of Aluminum, Cadmium, Copper, Lead, and Zinc by Human Scalp Hair and Elution of the Adsorbed Metals. Journal of Analytical Toxicology. 13(1). 17–21. 54 indexed citations
19.
Häfner, D., et al.. (1989). The pharmacokinetics of ticarcillin/clavulanate acid in neonates. Journal of Antimicrobial Chemotherapy. 24(suppl B). 111–120. 12 indexed citations
20.
Häfner, D., et al.. (1988). Electrophysiological characterization of the class III activity of sotalol and its enantiomers. New interpretation of use-dependent effects.. PubMed. 38(2). 231–6. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sanjay Batra Breakdown of academic impact, for papers by B. Sweder van Asbeck Breakdown of academic impact, for papers by Ying Dong Breakdown of academic impact, for papers by Annette J. Theron Breakdown of academic impact, for papers by Pinhua Pan Breakdown of academic impact, for papers by Joannes J.M. Marx Breakdown of academic impact, for papers by Charles E. McCall Breakdown of academic impact, for papers by Frances W.J. Beck Breakdown of academic impact, for papers by Xiaoyang Jiao Breakdown of academic impact, for papers by Charles R. Esther
Rankless by CCL
2026